Category: Consumer goods
Quick infos Headquarters: Tampa, Florida, United States Trade prices Volume: Market Cap: 85.17M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: October 22, 2021
Earnings History Date EPS / Forecast Revenue / Forecast October 22, 2021 August 30, 2021 -0.03 / -0.045- / -August 16, 2021 - / -0.045- / -May 18, 2021 -0.05 / -0.05- / -February 19, 2021 -0.06 / -0.06- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 27, 2021 0.6812 0.6949 0.7000
0.6800
1.59M -2.67% Aug 26, 2021 0.6999 0.6700 0.7000
0.6680
1.50M 5.41% Aug 25, 2021 0.6640 0.6491 0.6800
0.6491
1.38M 1.34% Aug 24, 2021 0.6552 0.6520 0.6680
0.6466
1.50M -0.58% Aug 23, 2021 0.6590 0.6200 0.6694
0.6200
1.56M 5.27% Aug 20, 2021 0.6260 0.6300 0.6444
0.6201
908.75K 0.16% Aug 19, 2021 0.6250 0.6430 0.6688
0.6155
2.04M -4.83% Aug 18, 2021 0.6567 0.6331 0.6800
0.6300
1.55M 0.72% Aug 17, 2021 0.6520 0.6050 0.6552
0.6003
3.33M 6.89% Aug 16, 2021 0.6100 0.6710 0.6749
0.6035
3.40M -7.2% view more
News
Oragenics rallies on encouraging data supporting potential COVID-19 vaccine seekingalpha.com Jul 22, 2020 9:19 pm Oragenics +13% on advancement of COVID-19 vaccine program seekingalpha.com Jul 10, 2020 7:51 pm Oragenics inks deal to advance COVID-19 vaccine seekingalpha.com May 19, 2020 8:13 pm
Oragenics, Inc. Receives Further Validation for Lantibiotic Compound OG716 app.quotemedia.com Jan 28, 2019 9:37 pm Oragenics enters the COVID-19 vaccine game; shares up 51% premarket seekingalpha.com May 16, 2020 4:01 am Oragenics' AG013 flunks mid-stage study; shares down 50% premarket seekingalpha.com Apr 15, 2020 7:43 pm Oragenics files for $50M equity offering seekingalpha.com Mar 5, 2020 5:06 am Oragenics (OGEN) Investor Presentation - Slideshow seekingalpha.com Nov 15, 2019 5:06 am Oragenics up 12% on advancement of oral mucositis candidate seekingalpha.com Aug 15, 2019 4:06 am Oragenics collaborates with FIU to expand lantibiotic pipeline seekingalpha.com May 17, 2019 4:00 am Oragenics closes $12.5M equity offering seekingalpha.com Mar 26, 2019 4:09 am Oragenics -13.1% on proposed equity offering seekingalpha.com Mar 21, 2019 6:19 am Oragenics up 23% seekingalpha.com Nov 30 11:22 pm Oragenics reports Q3 results seekingalpha.com Nov 15 1:21 pm Oragenics receives clearance to enroll patients into its Phase 2 trial of AG013 for oral mucositis seekingalpha.com Oct 17 9:35 pm Oragenics adds to rally, up 46% seekingalpha.com Oct 1 11:04 pm Premarket Losers as of 9:05 am (07/13/2018) seekingalpha.com Jul 13 9:17 pm Oragenics prices equity offering; shares down 31% premarket seekingalpha.com Jul 13 8:43 pm Oragenics files for equity offering seekingalpha.com Jul 6 7:30 pm Oragenics' AG013 shows favorable safety profile in mid-stage OM study; shares up 34% premarket seekingalpha.com May 30 7:55 pm Talk about Oragenics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!
